PPARG and pancreatic adenocarcinoma: We observed significant differences in PPARG expression in PAAD and LIHC tumors concerning lymph node metastasis status, histological subtype, molecular subtype, tumor stage, and TP53 mutation status (Supplementary Figures S2, S3).